Market Newsdesk

NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a class action lawsuit has been filed against AgEagle Aerial Systems, Inc. (“AgEagle” or the “Company”) (NYSE: UAVS) in the United States District Court for the Central District of California on behalf of those who purchased or acquired the securities of AgEagle between September 3, 2019 and February 18, 2021, inclusive (the “Class Period”). The lawsuit seeks to recover damages for investors under the federal securities laws.

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (i) AgEagle did not have a partnership with Amazon and in fact never had any relationship with Amazon; (ii) rather than correct the public’s understanding about a partnership with Amazon, Defendants were actively contributing to the rumor that AgEagle had a partnership with Amazon; and (iii) as a result, Defendants’ statements about AgEagle’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Investors who purchased or otherwise acquired shares of AgEagle during the Class Period should contact the Firm prior to the April 27, 2021 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.  If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at tjmckenna@gme-law.com or gegleston@gme-law.com.

Please visit our website at http://www.gme-law.com for more information about the firm.

MESA, Ariz., Feb. 26, 2021 (GLOBE NEWSWIRE) — We are advised by Top Aces Corp. that journalists and other readers should disregard the news release, “Top Aces Corp. Demonstrates Advanced Adversary Training Capabilities to USAFE” issued Feb. 25, 2021 over GlobeNewswire.

GUADALAJARA, Mexico, Feb. 26, 2021 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (the “Company” or “GAP”) announced that, in accordance with the approvals set by the Board of Directors, the Company will present for consideration at the Shareholders Meeting a shareholder distribution, which will be made through a capital reduction for up to Ps. 2 billion, payable in the next 12 months.

The Company also will propose a new maximum amount for the repurchase of shares for up to Ps. 3 billion for 2021, as well as the cancelation of 35,424,453 shares (6.3% of authorized shares), that are currently held in treasury as a result of repurchases in prior periods.

Company Description
Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (GAP) operates 12 airports throughout Mexico’s Pacific region, including the major cities of Guadalajara and Tijuana, the four tourist destinations of Puerto Vallarta, Los Cabos, La Paz and Manzanillo, and six other mid-sized cities: Hermosillo, Guanajuato, Morelia, Aguascalientes, Mexicali and Los Mochis. In February 2006, GAP’s shares were listed on the New York Stock Exchange under the ticker symbol “PAC” and on the Mexican Stock Exchange under the ticker symbol “GAP”. In April 2015, GAP acquired 100% of Desarrollo de Concesiones Aeroportuarias, S.L., which owns a majority stake in MBJ Airports Limited, a company operating Sangster International Airport in Montego Bay, Jamaica. In October 2018, GAP entered into a concession agreement for the operation of the Norman Manley International Airport in Kingston, Jamaica and took control of the operation in October 2019.

In accordance with Section 806 of the Sarbanes-Oxley Act of 2002 and article 42 of the “Ley del Mercado de Valores”, GAP has implemented a “whistleblower” program, which allows complainants to anonymously and confidentially report suspected activities that June involve criminal conduct or violations. The telephone number in Mexico, facilitated by a third party that is in charge of collecting these complaints, is 01 800 563 00 47. The web site is www.lineadedenuncia.com/gap. GAP’s Audit Committee will be notified of all complaints for immediate investigation.

NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Bit Digital, Inc. (NASDAQ: BTBT) between December 21, 2020 and January 8, 2021, inclusive (the “Class Period”), of the important March 22, 2021 lead plaintiff deadline.

SO WHAT: If you purchased Bit Digital securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Bit Digital class action, go to http://www.rosenlegal.com/cases-register-2023.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 22, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

WHAT IS THE CASE ABOUT: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Bit Digital overstated the extent of its a bitcoin mining operation; and (2) as a result, defendants’ positive statements about Bit Digital’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Bit Digital class action, go to http://www.rosenlegal.com/cases-register-2023.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        lrosen@rosenlegal.com
        pkim@rosenlegal.com
        cases@rosenlegal.com
        www.rosenlegal.com

CAMBRIDGE, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on Feb. 26, 2021 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to 2 individuals hired by Sarepta in February 2021. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

The employees received, in the aggregate, options to purchase 1,820 shares of Sarepta’s common stock, and in the aggregate 680 restricted stock units (“RSUs”). The options have an exercise price of $87.06 per share, which is equal to the closing price of Sarepta’s common stock on Feb. 26, 2021 (the “Grant Date”). One-fourth of the shares underlying each employee’s option will vest on the one-year anniversary of the Grant Date and thereafter 1/48th of the shares underlying each employee’s option will vest monthly, such that the shares underlying the option granted to each employee will be fully vested on the fourth anniversary of the Grant Date, in each case, subject to each such employee’s continued employment with Sarepta on such vesting dates.

One-fourth of the RSUs will vest yearly on each anniversary of the Grant Date, such that the RSUs granted to each employee will be fully vested on the fourth anniversary of the Grant Date, in each case, subject to each such employee’s continued employment with Sarepta on such vesting date.

About Sarepta Therapeutics


At Sarepta, we are leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people living with rare disease. The Company has built an impressive position in Duchenne muscular dystrophy (DMD) and in gene therapies for limb-girdle muscular dystrophies (LGMDs), mucopolysaccharidosis type IIIA, Charcot-Marie-Tooth (CMT), and other CNS-related disorders, with more than 40 programs in various stages of development. The Company’s programs and research focus span several therapeutic modalities, including RNA, gene therapy and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information

We routinely post information that may be important to investors in the ‘For Investors’ section of our website at 


www.sarepta.com


. We encourage investors and potential investors to consult our website regularly for important information about us.  

Source: Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.
Investors:
Ian Estepan, 617-274-4052, iestepan@sarepta.com

Media:
Tracy Sorrentino, 617-301-8566, tsorrentino@sarepta.com

Not
for
distribution
to
United
States
newswire
services
or
for
dissemination
in
the
United
States

VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) — West Mining Corp. (“West” or the “Company”) (CSE: WEST, OTC: WESMF, FRA: 1HL) is pleased to announce that it has closed its previously announced private placement financing (see the Company’s press release dated February 9, 2021). Under the financing, West has raised gross proceeds of $6,674,252 through the issuance of 11,248,500 units (each, a “Unit”) at a price of $0.40 per Unit and of 4,182,415 flow-through units (each, a “FT Unit”) at a price of $0.52 per FT Unit . Each Unit is comprised of one common share and one common share purchase warrant, each warrant exercisable for a common share at an exercise price of $0.60 for two years (subject to acceleration in certain circumstances). Each FT Unit is comprised of one flow-through common share and one common share purchase warrant, each warrant exercisable for a common share at an exercise price of $0.78 for one year (subject to acceleration in certain circumstances).

“The Company is extremely pleased with the appetite shown for the financing, and wish to thank all who participated,” commented Nicholas Houghton, President and CEO of West.

Under the financing, the Company paid a corporate finance fee of $10,000, paid aggregate finder’s fees of $446,139 and issued an aggregate of 1,029,655 finder’s warrants. 563,080 of the finder’s warrants are exercisable for a Unit at an exercise price of $0.40 for two years; 177,600 of the finder’s warrants are exercisable for a common share at an exercise price of $0.40 for two years; 137,028 of the finder’s warrants are exercisable for a unit (each comprised of one common share and one warrant exercisable for a common share at an exercise price of $0.78 for one year) at an exercise price of $0.52 for two years; and 151,947 of the finder’s warrants are exercisable for a common share at an exercise price of $0.52 for two years.

The securities issued under the private placement are subject to a four month hold period which expires June 27, 2021. The proceeds of the financing will be used for general working capital and for the exploration of the Company’s Kena Project, British Columbia.

The securities offered under the private placement have not been, nor will they be, registered
under the United States Securities Act of 1933, as amended, and may not be offered or sold in
the United States or to, or for the account or benefit of, U.S. persons absent registration or an
applicable exemption from the registration requirements. This press release shall not constitute
an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in
any
State in
which such
offer,
solicitation or sale would
be unlawful.

The Company has also issued an aggregate of 1,500,000 stock options to certain directors and consultants of the Company. Each option is exercisable for one common share at an exercise price of $1.10 per share for 10 years.

About
West
Mining
Corp.

West Mining Corp. is a mineral exploration company acquiring & developing advanced and prospective early-stage exploration projects. It is mainly focused on its Kena project in the Nelson Mining District of South Eastern British Columbia, with two other properties in British Columbia and one near Bathhurst, New Brunswick.

For additional information, please refer to the Company’s public disclosure record available on SEDAR at www.sedar.com.

West Mining Corp.

Nicholas Houghton
President & CEO
nick@westminingcorp.com

The


Canadian


Securities


Exchange


accepts


no


responsibility


for


the


adequacy


or


accuracy


of


this


release

.

Certain statements contained in this press release constitute “forward-looking information” as such term is defined
in applicable Canadian securities legislation. The words “may”, “would”, “could”, “should”, “potential”, “will”,
“seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions as they relate to
the
Company,
are
intended
to
identify
forward-looking
information.
All
statements
other
than
statements
of
historical
fact may be forward-looking information. Such statements reflect the Company’s current views and intentions with
respect
to
future
events,
and
current
information
available
to
them,
and
are
subject
to
certain
risks,
uncertainties
and
assumptions, including, without limitation: the potential of the Company’s mineral properties; the estimation of
capital requirements; the estimation of operating costs; the timing and amount of future business expenditures; and
the
availability
of
necessary
financing.
Many
factors
could
cause
the
actual
results,
performance
or
achievements
that
may be expressed or implied by such forward-looking information to vary from those described herein should one or
more of these risks or uncertainties materialize. Such factors include but are not limited to: changes in economic
conditions
or
financial
markets;
increases
in
costs;
litigation;
legislative,
environmental
and
other
judicial,
regulatory, political and competitive developments; and
exploration or operational difficulties. This list is not
exhaustive of the factors that may affect forward-looking information. These and other factors should be considered
carefully,
and
readers
should
not
place
undue
reliance
on
such
forward-looking
information.
Should
any
factor
affect
the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove
incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-
looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does
not
assume
responsibility
for
the
accuracy
or
completeness
of
such
forward-looking
information.
The
forward-looking
information
included
in
this press
release
is
made
as
of
the
date
of
this
press
release
and
the
Company
undertakes no
obligation
to
publicly update
or
revise any forward-looking information,
other
than as
required
by applicable law.